Products & ReviewLife Sciences
Cell-free Protein Synthesis
E. coli–based cell-free platform with 5BD TAT from sequence to protein.
Request Pricing
Receive your quote directly from the manufacturer.
Description
Designed for high-throughput screening and AI-driven antibody discovery, this platform enables rapid iteration and data generation at scale. It supports expression of enzymes, miniproteins, VHH, scFv, and Fab fragments, and integrates seamlessly with assay development and developability workflows—accelerating the path from sequence to data.
